RHINATHIOL Trademark

Trademark Overview

On Thursday, February 17, 2000, a trademark application was filed for RHINATHIOL with the United States Patent and Trademark Office. The USPTO has given the RHINATHIOL trademark a serial number of 75921425. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, November 16, 2012. This trademark is owned by Sanofi-Synthelabo. The RHINATHIOL trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparation for the treatment of the respiratory system
rhinathiol

General Information

Serial Number75921425
Word MarkRHINATHIOL
Filing DateThursday, February 17, 2000
Status710 - CANCELLED - SECTION 8
Status DateFriday, November 16, 2012
Registration Number3078004
Registration DateTuesday, April 11, 2006
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, January 17, 2006

Trademark Statements

Goods and Servicespharmaceutical preparation for the treatment of the respiratory system

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, November 16, 2012
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSANOFI-AVENTIS
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
Address75013 PARIS
FR
Party NameSANOFI-AVENTIS
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
Address75013 PARIS
FR
Party NameSanofi-Synthelabo
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
Address75013 Paris
FR

Trademark Events

Event DateEvent Description
Friday, November 16, 2012CANCELLED SEC. 8 (6-YR)
Tuesday, April 11, 2006REGISTERED-PRINCIPAL REGISTER
Tuesday, January 17, 2006PUBLISHED FOR OPPOSITION
Wednesday, December 28, 2005NOTICE OF PUBLICATION
Tuesday, December 6, 2005AMENDMENT/PETITION AFTER APPROVAL FOR PUB ENTERED
Tuesday, September 20, 2005ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
Tuesday, September 20, 20051(B) BASIS DELETED; NEW BASIS REQUESTED
Wednesday, January 19, 2005NOTICE OF ALLOWANCE CANCELLED
Tuesday, September 13, 2005PETITION TO REVIVE-GRANTED
Tuesday, September 13, 2005PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Friday, August 12, 2005PETITION TO REVIVE-RECEIVED
Friday, August 12, 2005PAPER RECEIVED
Thursday, February 17, 2005EXTENSION 4 GRANTED
Tuesday, January 18, 2005EXTENSION 4 FILED
Monday, January 24, 2005PAPER RECEIVED
Friday, August 27, 2004CASE FILE IN TICRS
Thursday, July 8, 2004EXTENSION 3 GRANTED
Wednesday, June 16, 2004EXTENSION 3 FILED
Wednesday, June 16, 2004PAPER RECEIVED
Monday, March 1, 2004EXTENSION 2 GRANTED
Friday, January 23, 2004EXTENSION 2 FILED
Friday, January 23, 2004PAPER RECEIVED
Thursday, July 17, 2003EXTENSION 1 GRANTED
Thursday, June 26, 2003EXTENSION 1 FILED
Thursday, June 26, 2003PAPER RECEIVED
Tuesday, February 25, 2003NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 3, 2002PUBLISHED FOR OPPOSITION
Wednesday, November 13, 2002NOTICE OF PUBLICATION
Thursday, September 19, 2002APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, September 12, 2002EXAMINERS AMENDMENT MAILED
Monday, September 9, 2002PREVIOUS ALLOWANCE COUNT WITHDRAWN
Saturday, April 6, 2002APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 15, 2002CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 16, 2001INQUIRY AS TO SUSPENSION MAILED
Wednesday, February 14, 2001LETTER OF SUSPENSION MAILED
Tuesday, October 3, 2000CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 20, 2000NON-FINAL ACTION MAILED
Wednesday, July 19, 2000ASSIGNED TO EXAMINER

Related Keywords

rhinathiol system respiratory treatment preparation pharmaceutical